# Canadian Solar Inc.: Form 20-F for the period ended Dec 31, 2024

- Company: [Canadian Solar Inc.](/companies/csiq.md) (CIK 1375877)
- Form: 20-F
- Filed: 2025-04-30
- Accepted by EDGAR: Apr 30, 2025, 16:06 ET
- Period: 2024-12-31
- Accession: 0001410578-25-001046
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1375877/000141057825001046/csiq-20241231x20f.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1375877/000141057825001046/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2024-12-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-01-01 to 2024-12-31 | $5.99bn | us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax |
| Cost of revenue | 12 months, 2024-01-01 to 2024-12-31 | $4.99bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2024-01-01 to 2024-12-31 | $999.3m | us-gaap:GrossProfit |
| Research and development | 12 months, 2024-01-01 to 2024-12-31 | $120.8m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months, 2024-01-01 to 2024-12-31 | −$30.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-01-01 to 2024-12-31 | $137.5m | us-gaap:InterestExpenseNonoperating |
| Income tax | 12 months, 2024-01-01 to 2024-12-31 | −$16.6m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 12 months, 2024-01-01 to 2024-12-31 | $0.54 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-01-01 to 2024-12-31 | $0.54 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-01-01 to 2024-12-31 | 66,939,428 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-01-01 to 2024-12-31 | −$885.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-01-01 to 2024-12-31 | $1.11bn | us-gaap:PaymentsToAcquireProductiveAssets |
| Cash and equivalents | at 2024-12-31 | $1.70bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2024-12-31 | $5.92bn | us-gaap:AssetsCurrent |
| Total assets | at 2024-12-31 | $13.51bn | us-gaap:Assets |
| Current liabilities | at 2024-12-31 | $5.42bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2024-12-31 | $9.36bn | us-gaap:Liabilities |
| Long-term debt | at 2024-12-31 | $4.60bn | us-gaap:LongTermDebt |
| Current portion of debt | at 2024-12-31 | $1.87bn | us-gaap:DebtCurrent |
| Short-term borrowings | at 2024-12-31 | $1.87bn | us-gaap:ShortTermBorrowings |
| Shareholders' equity | at 2024-12-31 | $2.82bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2024-12-31 | 66,954,634 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1375877/000141057825001046/csiq-20241231x20f.htm

Filed Apr 30, 2025.
Source: SEC EDGAR, the filing index for accession 0001410578-25-001046. Last ingested by Listed: Nov 3, 2026, 21:46 ET. No prices; not investment advice.